{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:29:12Z","timestamp":1738733352487,"version":"3.37.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41440-024-02008-8","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:08:13Z","timestamp":1732781293000},"page":"816-818","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of echocardiographic findings in patients with aldosterone-producing adenomas: adrenalectomy versus mineralocorticoid receptor antagonists"],"prefix":"10.1038","volume":"48","author":[{"given":"Tatsuya","family":"Haze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"2008_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327\u201359.","journal-title":"Endocr J"},{"key":"2008_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ajh\/hpu154","volume":"28","author":"L Marzano","year":"2014","unstructured":"Marzano L, Colussi G, Sechi LA, Catena C. Adrenalectomy Is Comparable With Medical Treatment for Reduction of Left Ventricular Mass in Primary Aldosteronism: Meta-Analysis of Long-Term Studies. Am J Hypertens. 2014;28:312\u201318.","journal-title":"Am J Hypertens"},{"key":"2008_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/HJH.0000000000003135","volume":"40","author":"A Aune","year":"2022","unstructured":"Aune A, Gerdts E, Kokorina M, Kringeland E, Midtb\u00f8 H, L\u00f8v\u00e5s K, et al. Persistent cardiac organ damage in surgically and medically treated primary aldosteronism. J Hypertens. 2022;40:1204\u201311.","journal-title":"J Hypertens"},{"key":"2008_CR4","doi-asserted-by":"crossref","unstructured":"Puar TH, Cheong CK, Foo RSY, Saffari SE, Tu TM, Chee MR, et al. Treatment of Primary Aldosteronism and Reversal of Renin Suppression Improves Left Ventricular Systolic Function. Front Endocrinol. 2022;13:916744.","DOI":"10.3389\/fendo.2022.916744"},{"key":"2008_CR5","doi-asserted-by":"crossref","unstructured":"Pan C-T, Wu X-M, Tsai C-H, Chang Y-Y, Chen Z-W, Chang C-C, et al. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism. Front Endocrinol. 2021;12:646097.","DOI":"10.3389\/fendo.2021.646097"},{"key":"2008_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013263","volume":"8","author":"YY Chang","year":"2019","unstructured":"Chang YY, Liao CW, Tsai CH, Chen CW, Pan CT, Chen ZW, et al. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score\u2013Matching Follow\u2010Up Study With Tissue Doppler Imaging. J Am Heart Assoc. 2019;8:e013263.","journal-title":"J Am Heart Assoc"},{"key":"2008_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/HJH.0000000000002679","volume":"39","author":"C Cuspidi","year":"2021","unstructured":"Cuspidi C, Tadic M, Sala C, Quarti-Trevano F, Gherbesi E, Mancia G, et al. Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies. J Hypertens. 2021;39:775\u201383.","journal-title":"J Hypertens"},{"key":"2008_CR8","doi-asserted-by":"publisher","unstructured":"Chan YC, Wu XM, Chen TY, Chen UL, Liao CW, Lai TS, et al. Evaluating the Effects of Adrenalectomy and Mineralocorticoid Receptor Antagonists on Cardiac Remodeling and Diastolic Function in Patients With Aldosterone-Producing Adenoma. Hypertens Res. 2024. https:\/\/doi.org\/10.1038\/s41440-024-01946-7.","DOI":"10.1038\/s41440-024-01946-7"},{"key":"2008_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41440-021-00719-w","volume":"44","author":"T Haze","year":"2021","unstructured":"Haze T, Hatakeyama M, Komiya S, Kawano R, Ohki Y, Suzuki S, et al. Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism. Hypertens Res. 2021;44:1341\u201351.","journal-title":"Hypertens Res"},{"key":"2008_CR10","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41440-023-01170-9","volume":"46","author":"T Haze","year":"2023","unstructured":"Haze T, Ozawa M, Kawano R, Haruna A, Ohki Y, Suzuki S, et al. Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism. Hypertens Res. 2023;46:1132\u201344.","journal-title":"Hypertens Res"},{"key":"2008_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11906-011-0182-2","volume":"13","author":"M Briet","year":"2011","unstructured":"Briet M, Schiffrin EL. The role of aldosterone in the metabolic syndrome. Curr Hypertens Rep. 2011;13:163\u201372.","journal-title":"Curr Hypertens Rep"},{"key":"2008_CR12","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41440-023-01538-x","volume":"47","author":"W-T Wang","year":"2024","unstructured":"Wang W-T, Wu T-H, Er L-K, Huang C-W, Tu K-H, Fan K-C, et al. Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review. Hypertens Res. 2024;47:1103\u201319.","journal-title":"Hypertens Res"},{"key":"2008_CR13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.ekir.2020.06.012","volume":"5","author":"Y Kobayashi","year":"2020","unstructured":"Kobayashi Y, Haze T, Yano Y, Tamura K, Kurihara I, Ichijo T, et al. Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism. Kidney Int Rep. 2020;5:1291\u201397.","journal-title":"Kidney Int Rep"},{"key":"2008_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41371-021-00595-4","volume":"36","author":"T Haze","year":"2022","unstructured":"Haze T, Yano Y, Hatano Y, Tamura K, Kurihara I, Kobayashi H, et al. Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function. J Hum Hypertens. 2022;36:904\u201310.","journal-title":"J Hum Hypertens"},{"key":"2008_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2021.03.033","volume":"324","author":"T Haze","year":"2021","unstructured":"Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, et al. Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. Atherosclerosis. 2021;324:84\u201390.","journal-title":"Atherosclerosis"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02008-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:03:14Z","timestamp":1738710194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-02008-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-02008-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}